[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_5024 

# __Ineffective antiviral composites__

## Articles mentionning the risk

* [Ayub_graphene-based_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_404.md)

## Mitigations of this risk

* [Regular testing and verification of antiviral activity](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_6897.md)

## Name of the risk

Failure to mitigate viral spread

## People affected by this risk

* [Manufacturers of antiviral composites](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_4231.md)

## Stakeholders who can mitigate this risk

* [Manufacturers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_34.md)

## Technologies linked to the risk

* [Laboratory assays](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6098.md)
* [Viral culture techniques](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6099.md)

## This Risk belongs to this RiskGroup

* [Technological risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_8.md)

